Cargando…
Clinical implications and perspectives of portal venous circulating tumor cells in pancreatic cancer
Despite recent improvements in the diagnosis and treatment of pancreatic cancer (PC), clinical outcomes remain dismal. Moreover, there are no effective prognostic or predictive biomarkers or options beyond carbohydrate antigen 19-9 for personalized and precise treatment. Circulating tumor cells (CTC...
Autores principales: | Ko, Sung Woo, Yoon, Seung Bae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134213/ https://www.ncbi.nlm.nih.gov/pubmed/37123055 http://dx.doi.org/10.4251/wjgo.v15.i4.632 |
Ejemplares similares
-
Prognostic Implications of Portal Venous Circulating Tumor Cells in Resectable Pancreatic Cancer
por: Choi, Young Hoon, et al.
Publicado: (2022) -
Torsion of spleen and portal hypertension: Pathophysiology and clinical implications
por: Jha, Ashish Kumar, et al.
Publicado: (2021) -
Sarcopenia in pancreatic cancer: Effect on patient outcomes
por: Choi, Moon Hyung, et al.
Publicado: (2022) -
Burden of venous thromboembolism in patients with pancreatic cancer
por: Frere, Corinne
Publicado: (2021) -
Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer
por: Takai, Erina, et al.
Publicado: (2016)